Nkarta, Inc. (NKTX) vs Oramed Pharmaceuticals Inc. (ORMP)

A side-by-side comparison of Nkarta, Inc. and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NKTX vs ORMP

growth of $100 · dividends reinvested · last 6y
NKTX -94.7% (-38.7%/yr)ORMP +45.0% (+6.4%/yr)ORMP compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$5$145
NKTX ORMP

NKTX vs ORMP: by the numbers

  • •ORMP is the larger company ($179M vs $165M market cap).
  • •ORMP is profitable (3202.50% net margin) while NKTX runs a net loss (0.00%).
  • •ORMP pays a dividend (5.59% yield), while NKTX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricNKTXORMP
P/E ratioN/A1.07
P/B ratio0.670.56

Profitability

MetricNKTXORMP
Gross margin0.00%0.65%
Operating margin0.00%-754.40%
Net margin0.00%3202.50%
ROE-47.36%55.08%
ROIC-42.11%-3.21%

Dividends

MetricNKTXORMP
Dividend yieldN/A5.59%
Payout ratioN/A6.08%

Growth (annualized)

MetricNKTXORMP
Total return CAGR (5Y)-37.28%-25.80%

Frequently asked

Does NKTX or ORMP pay a bigger dividend?
ORMP pays a dividend (5.59% yield), while NKTX has no payments in the available dividend history.
Is NKTX or ORMP more profitable?
ORMP runs the higher net margin — NKTX at 0.00% versus ORMP at 3202.50%.
How have NKTX and ORMP total returns compared?
Over the past 5 years, NKTX delivered -37.28% and ORMP delivered -25.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.